Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.60
Bid: 123.60
Ask: 124.20
Change: 1.80 (1.48%)
Spread: 0.60 (0.485%)
Open: 122.00
High: 125.40
Low: 122.00
Prev. Close: 121.80
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM

20 Mar 2013 14:57

RNS Number : 4832A
HICL Infrastructure Company Ld
20 March 2013
 



20 March 2013

 

HICL Infrastructure Company Limited (the "Company")

 

Result of Extraordinary General Meeting

 

The Board of the Company is pleased to announce that each of the special resolutions put to shareholders at the Extraordinary General Meeting held on 20 March 2013 were passed. The details of each such resolution are as follows: 

 

 

ORDINARY RESOLUTION 1

 

 

 

 

 

 

 

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

280,248,977

99.997

Against

8,000

0.003

 

That the proposed purchases by the Group from InfraRed Infrastructure Fund II of a 29.2 per cent. equity and loan note interest in the Bradford Schools Project and a 50 per cent. equity and loan note interest in the University of Sheffield Project on such terms as may be agreed by the Group and InfraRed Infrastructure Fund II, subject to all other actions necessary to effect such purchase, be and are hereby approved.

 

 

SPECIAL RESOLUTION 1

 

 

 

 

 

 

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

279,250,037

99.641

Against

1,006,940

0.359

 

That: (i) the Issue on the terms and subject to the conditions described in the Circular be and is hereby approved; and (ii) the Directors be and hereby are empowered to allot up to 140 million Ordinary Shares for cash (in substitution for any existing such power or authority other than pursuant to Special Resolution 2), as if Article 9 of the Company's Articles did not apply to the allotment, provided that:

(a) this power shall (unless previously revoked, varied or renewed by the Company) expire on 31 May 2013, provided that the Company may before such expiry, make an offer or agreement which would or might require Ordinary Shares to be allotted after such expiry and Ordinary Shares may be allotted in pursuance of such an offer or agreement as if the power conferred by this resolution had not expired; and

(b) this power shall be limited to the allotment of New Ordinary Shares under the Issue.

 

 

SPECIAL RESOLUTION 2

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

277,402,017

98.981

Against

2,854,960

1.019

 

That the Directors be and hereby are empowered to allot up to 10.0 per cent. of the Ordinary Shares of the Company in issue immediately following the completion of the Issue (or, if the Issue does not proceed, the date of the publication by the Company of an announcement to this effect) for cash (in substitution for any existing such power or authority other than pursuant to Special Resolution 1), as if Article 9 of the Company's Articles did not apply to the allotment for the period expiring on the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, which ever is the earlier, provided that the Company may before such expiry, make an offer or agreement which would or might require Ordinary Shares to be allotted after such expiry and Ordinary Shares may be allotted in pursuance of such an offer or agreement as if the power conferred by this resolution had not expired.

 

 

 

 

 

 In accordance with Listing Rule 9.6.2, a copy of the special resolutions above have been forwarded to the National Storage Mechanism.

 

For further information, please contact:

 

Gillian Newton/Christopher Copperwaite

Dexion Capital (Guernsey) Limited

 

 

+44 (0)1481 732814/732815

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGSEIFLSFDSEID
Date   Source Headline
26th Sep 20172:30 pmRNSAdditional Listing
14th Sep 20175:31 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSCompletion of Acquisition
1st Sep 20172:11 pmRNSScrip Share Reference Price
26th Jul 20178:25 amRNSPreferred Bidder Announcement
24th Jul 20177:00 amRNSInterim Update Statement
21st Jul 20173:00 pmRNSScrip Dividend Circular
18th Jul 20173:33 pmRNSFirst Quarterly Interim Dividend
14th Jul 20172:50 pmRNSAcquisition
5th Jul 20173:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:38 pmRNSTotal Voting Rights
22nd Jun 20172:00 pmRNSAdditional Listing
13th Jun 20178:44 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual Financial Report
5th Jun 20173:22 pmRNSResult of Equity Issue
2nd Jun 20171:24 pmRNSScrip Share Reference Price
24th May 20177:00 amRNSAnnual Results for the year ended 31 March 2017
24th May 20177:00 amRNSIssue of Equity
22nd May 20177:00 amRNSCompletion of Acquisition
18th May 201711:21 amRNSFourth Quarterly Interim Dividend
2nd May 20177:00 amRNSAcquisition of a new investment
2nd May 20177:00 amRNSIncrease in the Group's credit facility
10th Apr 20177:00 amRNSNotice of Annual Results
5th Apr 20174:00 pmRNSDirector/PDMR Shareholding
4th Apr 201710:28 amRNSHolding(s) in Company
3rd Apr 20178:00 amRNSIncremental Investment
31st Mar 20175:11 pmRNSTotal Voting Rights
29th Mar 20174:00 pmRNSDirector/PDMR Shareholding
24th Mar 20178:00 amRNSAdditional Listing and Total Voting Rights
22nd Mar 20174:00 pmRNSDirector/PDMR Shareholding
22nd Mar 201710:16 amRNSAdditional Listing
22nd Mar 20177:00 amRNSResult of Equity Issue
21st Mar 20179:28 amRNSTerms and Conditions of the Placing
20th Mar 201711:49 amRNSDirectorate Change
20th Mar 201711:36 amRNSResults of EGM
10th Mar 20178:00 amRNSCompletion of Acquisition
9th Mar 20172:37 pmRNSScrip Share Reference Price
23rd Feb 20175:41 pmRNSPublication of a Prospectus and Circular
23rd Feb 20175:00 pmRNSPublication of a Prospectus and Circular
22nd Feb 20174:45 pmRNSThird Quarterly Interim Dividend
2nd Feb 201711:44 amRNSInterim Update Statement February 2017
23rd Jan 20177:00 amRNSCompletion of Acquisition
12th Jan 20172:42 pmRNSIntention to issue new equity
5th Jan 20177:00 amRNSCompletion of Two Acquisitions
4th Jan 20174:00 pmRNSDirector/PDMR Shareholding
30th Dec 20164:00 pmRNSTotal Voting Rights
16th Dec 201612:32 pmRNSAdditional Listing
7th Dec 20163:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201610:00 amRNSDirector Declaration - Additional Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.